ASND Shares Shrug Off Positive European Opinion For FDA-Approved Achondroplasia Drug

Ascendis said the Committee for Medicinal Products for Human Use adopted a positive opinion on Ascendis’s application seeking approval for the drug in achondroplasia.
Read the full report on Asianet Newsable
Story file
- Section
- Business
- Topics
- Stock market
- First reported by
- Asianet Newsable
- Reporter
- stocktwits inc
- Published
- Saturday, 17 October 2026, 3:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.



